1. Home
  2. VTSI vs MAIA Comparison

VTSI vs MAIA Comparison

Compare VTSI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.25

Market Cap

61.9M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.41

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
MAIA
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
44.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VTSI
MAIA
Price
$4.25
$1.41
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
51.2K
1.0M
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$24,934,267.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
N/A
P/E Ratio
$299.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.57
$0.87
52 Week High
$7.47
$2.74

Technical Indicators

Market Signals
Indicator
VTSI
MAIA
Relative Strength Index (RSI) 32.24 55.23
Support Level $4.32 $1.13
Resistance Level $4.45 $1.64
Average True Range (ATR) 0.15 0.16
MACD -0.01 0.02
Stochastic Oscillator 10.56 45.16

Price Performance

Historical Comparison
VTSI
MAIA

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: